Seoul
South Korea
6
2023-09-28
6
2025-11-25
These are the the leading inventors for applications assigned to CHA BIOTECH CO., LTD.:
CHA BIOTECH CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
UMBILICAL CORD-DERIVED ADHERENT STEM CELLS, PREPARATION METHOD THEREFOR, AND USE THEREOF
#2 | 2021-12-09 ✅ Patent 12,319,936 granted on 2025-06-03Natural killer cells exhibiting increased anticancer activity and immunotherapeutic use thereof
#3 | 2021-11-04 ✅ Patent 12,371,664 granted on 2025-07-29MEDIUM FOR DIRECT DIFFERENTIATION OF PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL, METHOD FOR PREPARING MESENCHYMAL STEM CELL BY USING SAME, AND MESENCHYMAL STEM CELL PREPARED THEREBY
#4 | 2018-07-26 ✅ Patent 12,091,679 granted on 2024-09-17Storage method and banking system of NT cell
#5 | 2018-04-26 ✅ Patent 10,479,978 granted on 2019-11-19Postnatal adherent cells and preparation method therefor
#6 | 2017-10-19 ✅ Patent 11,351,194 granted on 2022-06-07Method for proliferating neural progenitor cells and composition for treating neurological diseases containing proliferated neural progenitor cells
Also check out CHA BIOTECH CO., LTD.'s (Seoul, South Korea) applicant profile with 5 patent applications submitted.
134314 ⎘